Skip to main content

Oncorus, Inc.

ONCRDelisted Jul 10, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001671818

Oncorus, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Dec 30, 2022; 32 institutions reported holding it in 13F filings for Q1 2023, worth $3.78M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding Oncorus, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of ONCR: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders56245−9
Shares19.4M57.8K17.0M−2.36M (−12.2%)
Value$34.5M$103.0K$21.4M−$13.0M (−37.8%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (6)

Institutions that held Oncorus, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to ONCR in Q2 2022
InstitutionSharesValue% of portfolio
Millennium Management LLC377,732$476.0K0.00%
Ergoteles LLC98,600$124.0K0.00%
Susquehanna International Group, LLP41,192$52.0K0.00%
Qube Research & Technologies Ltd17,874$23.0K0.00%
UBS Group AG8,016$10.0K0.00%
Credit Suisse AG11$00.00%

Sold out (15)

Institutions that held Oncorus, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (2)

Institutions that held Oncorus, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ONCR in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC55,355$99.0K
Amalgamated Financial Corp.2,459$4.00K